More articles from Volume 44, Issue 1, 2015
HLORINIŠUĆA AKTIVNOST SERUMSKE MIJELOPEROKSIDAZE U AKUTNOM ISHEMIČNOM MOŽDANOM UDARU
KVANTITATIVNA ANALIZA MAKROFAGA U GINGIVITISU I PARODONTOPATIJI
Is hypertension, in children who are on chronic hemodialysis therapy, crucial for the development of cardiac hypertrophy?
LEČENJE INFERTILNIH I SUBFERTILNIH MUŠKARACA SA VARIKOKELOM MINIMALNO INVAZIVNIM HIRURŠKIM METODOM
HISTOLOŠKO-CITOLOŠKA KORELACIJA NALAZA I POUZDANOST PAPANICOLAU TESTA U OTKRIVANJU PREMALIGNIH I MALIGNIH PROMENA NA GRLIĆU MATERICE
MORFOLOŠKO-KLINIČKE KARAKTERISTIKE KARCINOMA KOŽE GLAVE EPIDERMALNOG POREKLA
,
M. Mijović
,
N. Mitić
,
B. Đerković
,
M. Filipović
,
S. Savić
,
S. Leštarević
A. Ilić
Abstract
Keywords
References
1.
Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;975–83.
2.
Aszterbaum M, Beech J, Ehjr E. Ultraviolet light radiation mutagenesis of hedgehog pathway genes in basal cell carcinomas. J Invest Dermatol Symp Proc. 1999;41–5.
3.
Aszterbaum M, Rothman A, Johnson R, Fisher M, Xie J, Bonifas J, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 1998;885–8.
4.
Aurora A, Luxenberg M. Case report of adenocarcinoma of glands of Moll. Am J Ophthalmol. 1970;984–90.
5.
Blessing K, Mclaren K, Morris R, Barr B, Benton E, Alloub M, et al. Detection of human papillomavirus in skin and genital lesions of renal allograft recipients by in situ hybridization. Histopathology. 1990;181–5.
6.
Boyd A, Shyr K, Lejr. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol. 2002;706–9.
7.
Bozdogan O, Erkek E, Atasoy P, Kocak M, Birol A, Caydere M. Bcl-2-related proteins, alpha-smooth muscle actin and amyloid deposits in aggressive and non-aggressive basal cell carcinomas. Acta Derm Venereol. 2002;423–7.
8.
Brown C, Perry A. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol. 2000;123–5.
9.
Buettner P, Raasch B. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer. 1998;587–93.
10.
De Gruijl F, Longstreth J, Norval M, Cullen A, Slaper H, Kripke M, et al. Health effects from stratospheric ozone depletion and interactions with climate change. Photochem Photobiol Sci. 2003;16–28.
11.
Dinehart S. The treatment of actinic keratoses. J Am Acad Dermatol. 2000;25–8.
12.
Dixon A, Lee S, Mcgregor D. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol. 1993;137–42.
13.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, et al. 2000;
14.
Gailani M, Stahle-Backdahl M, Leffell D, Glynn M, Zaphiropoulos P, Pressman C, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet. 1996;78–81.
15.
Giles G, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed). 1988;13–7.
16.
Grant-Kels M. Color atlas of dermatopathology, Informa Healthcare. 2007;191–208.
17.
Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol. 1996;1034–40.
18.
Green A, Beardmore G, Hart V, Leslie D, Marks R, Staines D. Skin cancer in a Queensland population. J Am Acad Dermatol. 1988;1045–52.
19.
Guo H, Yu H, Hu H, Monson R. Arsenic in drinking water and skin cancers: cell-type specificity. Cancer Causes Control. 2001;909–16.
20.
Hanke C, Wolf R, Hochman S, ’brian O, J. Chemosurgical reports: perineural spread of basal-cell carcinoma. J Dermatol Surg Oncol. 1983;742–7.
21.
Kao G. Arch Dermatol. 1986;1124–6.
22.
Karagas M. Occurrence of cutaneous basal cell and squamous cell malignancies among those with a prior history of skin cancer. The Skin Cancer Prevention Study Group. J Invest Dermatol. 1994;
23.
Khanna M, Fortier-Riberdy G, Smoller B, Dinehart S. Reporting tumor thickness for cutaneous squamous cell carcinoma. J Cutan Pathol. 2002;321–3.
24.
Kim M, Park H, Baek S, Byun D, Houh D. Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci. 2002;1–9.
25.
Kubo Y, Murao K, Matsumoto K, Arase S. Molecular carcinogenesis of squamous cell carcinomas of the skin. J Med Invest. 2002;111–7.
26.
Langard S, Rosenberg J, Andersen A, Heldaas S. Incidence of cancer among workers exposed to vinyl chloride in polyvinyl chloride manufacture. Occup Environ Med. 2000;65–8.
27.
Lear J, Smith A, Heagerty A, Bowers B, Jones P, Gilford J, et al. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma. Carcinogenesis. 1997;1499–503.
28.
Leboit E, Burg G, Weedon D, Sarasin A. Pathology and Genetics, Skin Tumours. 2006;9–33.
29.
Lerchin E, Rahbari H. Adamantinoid basal cell epithelioma. A histological variant. Arch Dermatol. 1975;586–8.
30.
Lever W. 2005;805–66.
31.
Lo J, Snow S, Reizner G, Mohs F, Larson P, Hruza G. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;715–9.
32.
Lund H. How often does squamous cell carcinoma of the skin metastasize? Arch Dermatol. 1965;635–7.
33.
Manstein C, Gottlieb N, Manstein M, Manstein G. Giant basal cell carcinoma: a series of seven T3 tumors without metastasis. Plast Reconstr Surg. 2000;653–6.
34.
Mccormack C, Kelly J, Dorevitch A. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol. 1997;593–6.
35.
Moller R, Reymann F, Hou-Jensen K. Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol. 1979;703–5.
36.
Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002;18–25.
37.
Nguyen M, Song S, Liem A, Androphy E, Liu Y, Lambert P. A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. J Virol. 2002;13039–48.
38.
Nguyen P, Vin-Christian K, Ming M, Berger T. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol. 2002;758–63.
39.
Ortonne J. From actinic keratosis to squamous cell carcinoma. Br J Dermatol. 2002;20–3.
40.
Rahbari H, Mehregan A. Basal cell epithelioma (carcinoma) in children and teenagers. Cancer. 1982;350–3.
41.
Ramdial P, Madaree A, Reddy R, Chetty R. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas. J Cutan Pathol. 2000;283–91.
42.
Rippey J, Rippey E. Characteristics of incompletely excised basal cell carcinomas of the skin. Med J Aust. 1997;581–3.
43.
Robinson J, Dahiya M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol. 2003;643–8.
44.
Rowe D, Carroll R, Cljr D. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;976–90.
45.
Wjjr S, Snow S, Levine N. Giant basal cell carcinoma. Reportof two cases and review of the literature. J Am Acad Dermatol. 1994;856–9.
46.
Sanchey R, Raimer S. Dermatopathology, Landes Bioscience, USA. 2001;209–34.
47.
Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;41–7.
48.
Simeonova P, Luster M. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol. 2000;281–6.
49.
Smith S, Grande D. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol. 1991;26–30.
50.
Tellechea O, Reis J, Domingues J, Baptista A. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol. 1993;452–5.
51.
Turner R, Leonard N, Malcolm A, Lawrence C, Dahl M. A retrospective study of outcome of Mohs’ micrographic surgery for cutaneous squamous cell carcinoma using formalin fixed sections. Br J Dermatol. 2000;752–7.
52.
Unden A, Zaphiropoulos P, Bruce K, Toftgard R, Stahle-Backdahl M. Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res. 1997;2336–40.
53.
Von Domarus H, Stevens P. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;1043–60.
54.
Wang M, Cheng G, Sturla S, Shi Y, Mcintee E, Villalta P, et al. Identification of Adducts Formed by Pyridyloxobutylation of Deoxyguanosine and DNA by 4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a Chemically Activated Form of Tobacco Specific Carcinogens. Chem Res Toxicol. 2003;616–26.
55.
Wassberg C, Thorn M, Johansson A, Bergstrom R, Berne B, Ringborg U. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol. 2001;268–72.
56.
Weinstock M. Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study. J Invest Dermatol. 1994;(6).
57.
Weinstock M. Death from skin cancer among the elderly: epidemiological patterns. Arch Dermatol. 1997;1207–9.
58.
Xie J, Murone M, Luoh S, Ryan A, Gu Q, Zhang C, et al. Activating Smoothened mutations in sporadic basalcellcarcinoma. Nature. 1998;90–2.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
